Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma.

ABSTRACT:

SUBMITTER: Li B 

PROVIDER: S-EPMC11791609 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature